台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    102.5
  • 漲跌
    ▼0.5
  • 漲幅
    -0.49%
  • 成交量
    55
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-群益金鼎-建成 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-建成 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/221103.0000.00103.0011570.64%
2024/05/213102.3300.00102.0031551.93%
2024/05/171104.5000.00105.5011520.66%
2024/05/1000.001118.50118.50-1120-0.83%
2024/05/0900.003118.50118.50-3119-2.50%
2024/04/085123.2000.00123.505736.81%
2024/03/181123.0000.00124.001511.95%
2024/01/1700.002111.50112.00-229-6.85%
2023/11/0100.001.1114.55114.00-1.120-5.25%
2023/04/2600.001108.00108.50-153-1.89%
2023/04/2100.001107.50108.00-153-1.88%
2023/03/2200.001115.50115.50-129-3.38%
2023/03/152113.0000.00113.002306.56%
2022/12/2600.001107.00107.00-140-2.50%
2022/11/1000.004101.00101.00-419-20.65%
2022/11/0400.00699.0399.20-619-31.44%
2022/11/031100.5000.00101.001195.24%
2022/11/0200.00199.2099.00-118-5.30%
2022/10/311100.5000.0099.201175.66%
2022/10/201100.5000.00101.001156.40%
2022/10/181101.5000.00101.501146.70%
2022/10/171102.5000.00102.001146.77%
2022/10/031104.5000.00103.501166.03%
2022/09/292106.0000.00106.0021612.50%
2022/09/282105.5000.00106.0021512.55%
2022/09/271104.501104.00106.500160.00%
2022/09/2600.001106.50105.00-116-6.06%
2022/09/162108.2500.00108.0021611.88%
2022/09/1400.001106.00107.50-117-5.61%
2022/09/121109.5000.00107.501175.70%
2022/09/051108.0000.00108.001175.67%
2022/05/17197.9000.0098.001422.33%
2022/05/131101.0000.00102.501402.50%
2022/05/121109.0000.00109.001332.98%
2022/04/151125.0000.00124.501253.88%
2021/10/251130.0000.00130.001372.67%
2021/08/162147.0000.00146.502375.38%
2021/08/110.1149.5000.00149.500.1350.28%
2021/04/221146.0000.00146.501372.64%
2021/04/1900.001147.50147.50-138-2.63%
2021/04/121150.5000.00150.501362.77%
2021/03/1800.001135.00135.00-125-3.95%
2021/03/1700.000.4134.50134.00-0.425-1.53%
2020/07/271107.0000.00105.501631.58%
2020/06/3000.001107.50107.50-162-1.61%
2020/05/1100.002.5107.11106.00-2.544-5.52%
2020/05/051101.0000.00101.001422.38%
2020/04/3000.001102.00102.00-141-2.42%
2020/04/0800.00198.5098.80-142-2.33%
2020/04/07199.0000.0098.801422.33%
2020/03/25296.5000.0095.702404.91%
2020/03/12298.5000.0098.102306.66%
2020/03/101100.0000.00100.001283.54%
2020/03/061100.0000.00101.001263.78%
2020/02/1900.001101.00101.00-125-3.85%
2019/12/181103.0000.00102.501204.99%
2019/11/2000.001101.50102.00-121-4.75%
2019/09/251102.5000.00102.001342.89%
2019/08/1600.001102.00102.00-143-2.32%
2019/08/011102.5000.00103.001452.19%
2019/07/2900.001102.00102.00-146-2.17%
2019/03/281109.0000.00108.501313.16%
2019/03/273109.5000.00109.503319.50%
2019/03/2000.001111.50112.00-129-3.38%
2019/03/1900.001111.50111.50-128-3.45%
2019/03/1800.001111.50111.50-126-3.79%
2019/03/1500.001111.00111.50-125-3.87%
2019/02/150.3108.5000.00108.000.3211.57%
2018/10/051103.0000.00103.001452.20%
2018/09/072106.2500.00106.002523.78%
2018/08/061112.501113.50113.000640.00%
2018/08/021112.5000.00112.501691.44%
2018/07/3000.001110.50110.50-181-1.22%
2018/07/251126.0000.00127.001871.15%
2018/05/0700.001130.00131.50-1124-0.80%
2018/03/2700.002129.50129.00-2163-1.22%
2018/03/1900.001129.00127.50-1176-0.57%
2018/03/061118.5000.00119.5011760.57%
2018/03/0200.002121.25120.00-2175-1.14%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音